申请人:Murata Toshiki
公开号:US20060205676A1
公开(公告)日:2006-09-14
Pyrimidine compounds of general formula:
wherein —R
1
represents
in which R
11
is hydrogen, C
1-6
alkyl, halogen, hydroxy, C
1-12
alkoxy, nitro, amino, C
1-6
alkylsulfonylamino, C
1-6
alkoxycarbonyl, C
1-6
alkylamino, di (C
1-6
alkyl)amino, C
1-6
alkanoylamino, phenyl C
1-6
alkylamino, phenylsulfonylamino, or —O—(CH
2
)
n
—R
111
; R
2
represents hydrogen or halogen; R
3
represents hydrogen, —CR
31
R
32
R
33
; R
4
is hydrogen, carbamoyl, CN, carboxyl, etc.; R
5
is amino, C
1-6
alkylamino, di C
1-6
alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.
通式为的
嘧啶类化合物:其中-R1代表其中R11为氢,C1-6烷基,卤素,羟基,C1-12烷氧基,硝基,
氨基,C1-6烷基磺酰
氨基,C1-6烷氧羰基,C1-6烷基
氨基,双(C1-6烷基)
氨基,C1-6烷酰胺基,苯基C1-6烷基
氨基,苯基磺酰
氨基或-O-(
CH2)n-R111;R2代表氢或卤素;R3代表氢,-CR31
R32R33;R4为氢,
氨基甲酰基,
氰基,羧基等;R5为
氨基,C1-6烷基
氨基,双C1-6烷基
氨基等或其盐。该化合物具有优异的抗炎活性和其他
生物活性。